维普中文期刊产品整合服务
19篇 您的检索式:作者名="COUTELLE O"
    题名 作者 年代 出处 被引量
1Recent developments in adeno-associated virus vector technology显示文摘Büning H Perabo L Coutelle O 2008J Gene Med2008,10,7:1
2Hedgehog signaling is required for maintenance of Myf-5 and MyoD expression and timely terminal differentiaion in zebrafish adaxial myogenesis显示文摘COUTELLE O BLAGDEN C S HAMPSON R 2001Developmental Biology2001,236,1:1
3Recent develop- ments in adeno-associated virus vector technology 显示文摘BUNING H PERABO L COUTELLE O 2008J Gene Med2008,10,7:1
4Strategies for the episomal modification of cells显示文摘Wong S P Argyros O Coutelle C 2009Curr Opin Mol Ther2009,11,4:1
5Analysis of Tie2-expressing monocytes (TEM) in patients with colorectal cancer 显示文摘Goede V Coutelle O Shimabukuro-Vornhagen A 2012Cancer Invest2012,30,3:1
6Re-cent developments in adeno-associated virus vector technology显示文摘Büning H Perabo L Coutelle O Quadt-Humme S Hallek M 2008J Gene Med2008,10,7:1
7Analysis of Tie2-spressing monocytes (TEM) in patients with colorectal cancer显示文摘Goede V Coutelle O Shimabukuro-Vornhagen A 0,,03:1
8Identification of serum angiopoietin-2 as a biomarker for clinical outcome of colorectal cancer patients treated with bevacizumab-containing therapy显示文摘Goede V Coutelle O Neuneier J 0,,09:1
9Strategies for the episomal modification of cells显示文摘Wong S P Argyros O Coutelle C 2009Curr Opin Mol Ther2009,11,:1
10Non-viral S/MAR vectors replicate episomally in vivo when provided with a selective advantage显示文摘Wong S P Argyros O Coutelle C 2011Gene Ther2011,18,:1
11Strategies for the episomal modification of ceils 显示文摘Wong S P Argyros O Coutelle C 2009Curr Opin Mol Ther2009,11,4:1
12Identification of serum an- giopoietin-2 as a biomarker for clinical outcome of colorectal cancer patients treated with bevacizumab-containing therapy显示文摘Goede V Coutelle O Neuneier J 2010Br J Canc- er2010,103,9:1
13Analysis of Tie2-expressing monocytes (TEM) in patients with colorectal cancer显示文摘Goede V Coutelle O Shimabukuro-Vornhagen A 2012Cancer Invest2012,30,3:1
14Identification of serum angiopoietin-2 as a biomarker for clinical outcome of colorectaI cancer patients treated with bevacizumab-contai- ning therapy显示文摘Goede V Coutelle O Neuneier J 2010Br J Cancer2010,103,9:1
15Identification of serum angiopoietin-2 as a biomarker for clinical outcome of colorectal cancer patients treated with bevacizumab-containing therapy显示文摘Goede V Coutelle O Neuneier J 2010Br J Cancer2010,103,9:1
16Analysis of Tie2 - spressing monocytes (TEM) in patients with colorectal cancer显示文摘Goede V Coutelle O Shimabukuro - Vornhagen A 2012Cancer Invest2012,30,3:1
17Hedgehog signalling is required for maintenance of myf5 and myoD expression and timely terminal differentiation in zebrafish adaxial myogenesis显示文摘Coutelle O Blagden CS Hampson R 2001Dev Biol2001,236,1:1
18Hedgehog signal- ling is required for maintenance of myf5 and myoD expres- sion and timely terminal differentiation in zebrafish adaxial myogenesis显示文摘Coutelle O Blagden C S Hampson R 2001Dev Biol2001,236,1:1
19Hedgehog signalling is required for maintenance of myf5 and myoD expression and timely terminal differentiation in zebrafish adaxial myogenesis显示文摘Coutelle O Blagden C S Hampson R 2001Developmental Biology2001,236,1:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费